share_log

快讯:新冠检测、医药股持续走低 明德生物、润达医疗、中源协和跌停

News flash: COVID-19 testing and pharmaceutical stocks continue to fall by the limit of Mingde Biology, Runda Medical and Vcanbio.

新浪財經綜合 ·  Jan 17, 2022 22:07

January 18 news, COVID-19 testing, pharmaceutical stocks continued to decline. As of press time, more than 10 shares of Mingde Biology, Runda Medical, Vcanbio fell by the limit, Aotai Biology, Guangshengtang, Zhijiang Biology, Hot scenery Biology, Meikang Biology, Yangpu Medical treatment, Longshen Rongfa and so on fell more than 10%.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment